Increased accumulation of the glycoxidation product N(ε)- (carboxymethyl)lysine in human tissues in diabetes and aging

Journal of Clinical Investigation

Volumn 99, Issue 3, 1997, Pages 457-468

  Schleicher, Erwin D ^a,d   Wagner, Eva ^b   Nerlich, Andreas G ^c  

^a Department for Internal Medicine   (Germany)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atherosclerosis; Complications of diabetes; Glycation; N( )(carboxymethyl)lysine; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; CATALASE; DEFEROXAMINE; GLYCOSYLATED PROTEIN; LYSINE DERIVATIVE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FETUS; GLUCOSE OXIDATION; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY; LUNG; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN; TISSUE DISTRIBUTION;

EID: 0030763201     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119180     Document Type: Article

References (45)

1. Kennedy. L., and J.W. Baynes. 1984. Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia. 26:93-98.
2. Lyons, T.J., and L. Kennedy. 1985. Non-enzymatic glycosylation of skin collagen in patients with limited joint mobility. Diabetologia. 28:2-5.
3. Vishwanatha, V., K.E. Frank, C.A. Elmets, P.J. Dauchot, and V.M. Monnier. 1986. Glycation of skin collagen in type 1 diabetes melliltus: correlation with long-term complications. Diabetes. 35:916-921.
4. Vogt, B., E. Schleicher, and O.H. Wieland. 1982. ∈-Amino-lysine-bound glucose in human tissues obtained at autopsy: increase in diabetes mellitus. Diabetes. 31:1123-1127.
5. Schleicher, E., and O.H. Wieland. 1986. Kinetic analysis of glycation as a tool for assessing the half-life of proteins. Biochim. Biophys. Acta. 884:199-205.
6. ∈-(car-boxymethyl)hydroxylysine in human skin collagen. Biochemistry. 30:1205-1210.
7. Dyer, D.G., J.A. Dunn. S.R. Thorpe. K.E. Bailie, T.J. Lyons, D.R. McCance, and J.W. Baynes. 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91:2463-2469.
8. ∈-(carboxymethyl)lysine in lens protein. Biochemistry. 28:9464-9468.
9. Pongor, S., P.C. Ulrich, F.A. Bencsath, and A. Cerami. 1984. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. USA. 81:2684-2688.
10. Ledl, F., and E. Schleicher. 1990. New aspects of the Maillard reaction in foods and in the human body. Angew. Chem. Int. Ed. Engl. 6:565-594.
11. Chang, J.C.F., P.C. Ulrich, R. Bucala, and A. Cerami. 1985. Detection of an advanced glucosylation product bound to protein in situ. J. Biol. Chem. 260: 7970-7974.
12. Brownlee, M., A. Cerami, and H. Vlassara. 1988. Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321.
13. Bucala, R., and A. Cerami. 1992. Advanced glycosylation: chemistry, biology and implications for diabetes in aging. Adv. Pharmacol. 23:1-34.
14. Makila, Z., H. Vlassara, A. Cerami, and R. Bucala. 1992. Immunochemical detection of advanced glycosylation endproducts in vivo. J. Biol. Chem. 267:5133-5138.
15. Monnier, V.M., R.R. Kohn, and A. Cerami. 1984. Accelerated age-related browing of human collagen in diabetes mellitus. Proc. Natl. Acad. Sci. USA. 81:583-587.
16. Dominiczak, M.H., J. Bell, N.H. Cox. D.C. McCruden, S.K. Jones, A.Y. Finlay, I.W. Percy-Robb and B.M. Frier. 1990. Increased collagen-linked fluorescence in skin of young patients with type 1 diabetes mellitus. Diabetes Care. 13:468-472.
17. Monnier, V.M., V. Vishwanatha, K.E. Frank, C.A. Elmets, P.J. Douchot, and R.R. Kohn. 1986. Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314:403-408.
18. Sell, D.R., and V.M. Monnier. 1989. Structure elucidation of a senescense cross-link from human extracellular matrix: implication of pentosidine in the aging process. J. Biol. Chem. 264:21597-21602.
19. Njoroge, F.G., L.M. Sayre, and V.M. Monnier. 1987. Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr. Res. 167:211-220.
20. ∈(carboxymethyl)lysine as a degradation product of fructose lysine in glycated protein. J. Biol. Chem. 261:4889-4894.
21. ∈(1-deoxy-D-fructos-1-yl)hippuryl-lysine. Eur. J. Biochem. 210:729-739.
22. Baynes, J.W. 1991. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405-412.
23. Fu, M.X., K.J. Knecht, S.R. Thorpe, and J.W. Baynes. 1992. Role of oxygen in cross-linking and chemical modifications of collagen by glucose. Diabetes. 41:42-48.
24. ∈-carboxymethyllysine: a new Maillard reaction product in rat urine. J. Agric. Food Chem. 35:427-431.
25. Knecht. K.J., J.A. Dunn, K.F. McFarland, D.R. McCance, T.J. Lyons, S.R. Thorpe, and J.W. Baynes. 1991. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 40:190-196.
26. Sell, D.R., E.C. Carlson, and V.M. Monnier. 1993. Differential effects of type 2 (noninsulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane. Diabetologia. 36:936-941.
27. Sell, D.R., A. Lapolla, P. Odetti, J. Fogarty, and V.M. Monnier. 1992. Pentosidine formation in skin correlates with severity of complication in individuals with long-standing IDDM. Diabetes. 41:1286-1292.
28. McCance, D.R., D.O. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, and J.W. Baynes. 1993. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 91:2470-2478.
29. Beisswenger, P.J., L.L. Moore, and T. Brink-Johnsen. 1993. Increased collagen-linked pentosidine levels and advanced glucosylation endproducts in early diabetic nephropathy. J. Clin. Invest. 92:212-217.
30. Schleicher, E., and O.H. Wieland. 1981. Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins. J. Clin. Chem. Clin. Biochem. 19:81-87.
31. Gempel, K., E. Wagner, and E. Schleicher. 1994. Characterization of antibodies against carboxymethyllysine-modified proteins. In Maillard reactions in chemistry, food and health. T.P. Labuza, G.A. Reineccius, V.M. Monnier, J. O'Brien, and J.W. Baynes, editors. The Royal Society of Chemistry, Cambridge. 392-396.
32. Nerlich, A., and E. Schleicher. 1991. Immunohistochemical localization of extracellular matrix in human diabetic glomerular lesions. Am. J. Pathol. 139: 889-899.
33. Dolhofer-Bliesener, R., B. Lechner, and K.-D. Gerbitz. 1994. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation. Eur. J. Clin. Chem. Clin. Biochem. 32:329-336.
34. Wells-Knecht, M.C., S.R. Thorpe, and J.W. Baynes. 1995. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:15134-15141.
35. ∈-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 35:8075-8083.
36. Horiuchi, S., N. Araki, and Y. Morino. 1991. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol. Chem. 266:7329-7332.
37. Vlassara, H., M. Brownlee, and A. Cerami. 1985. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc. Natl. Acad. Sci. USA. 82:5588-5592.
38. ∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:9982-9986.
39. Miyata, S., and V.M. Monnier. 1992. Immunohistochemical detection of advanced glycation endproduct in diabetic tissue using monoclonal antibody to pyrraline. J. Clin. Invest. 89:1102-1112.
40. Nakamura, Y. Y. Horii, T. Nishino, H. Shiiki, Y. Sakaguchi, T. Kagoshima, K. Dohi, Z. Makita, H. Vlassara, and R. Bucala. 1993. Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143:1649-1656.
41. Kume, S., M. Takeya, T. Mori. N. Araki. H. Suzuki, S. Horiuchi, T. Kodama, Y. Miyauchi, and K. Takahashi. 1995. Immunohistochemical and ultrastructural detection of advanced glycalion end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147:654-667.
42. ∈-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) in tissue proteins. Biochemistry. 34:10872-10878.
43. Mitushashi, T., H. Nakayama, T. Itoh. S. Kuwajima. S. Aoki. T. Atsumi. and T. Koide. 1993. Immunochemical detection of advanced glycation endproducts in renal cortex from STZ-induced diabetic rats. Diabetes. 42:826-832.
44. Fu, M.X., K.J. Wells-Knecht, J.A. Blackledge, T.J. Lyons. S.R. Thorpe, and J.W. Baynes. 1994. Glycalion. glycosylation. and cross-linking of collagen by glucose. Kinetics, mechanims, and inhibition of the late stages of the Maillard reaction. Diabetes. 43:676-683.
45. Palinsky, W., T. Koschinsky, S.W. Butler. E. Miller. H. Vlassara. A. Cerami, and J.L. Witztum. 1995. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Anerioscler. Thromb. Vase. Biol. 15:571-582.